➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Colorcon

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

SIMULECT Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for SIMULECT

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Peking University People's HospitalPhase 4
The Affiliated Hospital Of Guizhou Medical UniversityPhase 4
Hainan General HospitalPhase 4

See all SIMULECT clinical trials

Recent Litigation for SIMULECT

Identify key patents and potential future biosimilar entrants

PTAB Litigation
PetitionerDate
2017-12-20
2012-09-25

See all SIMULECT litigation

Patent Text Search: US Patents for SIMULECT

These patents were identified by searching patent claims

Supplementary Protection Certificates for SIMULECT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122011100063 Germany   Start Trial PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
132016000070123 Italy   Start Trial PRODUCT NAME: RITUXIMAB IN ASSOCIAZIONE CON IALURONIDASI RICOMBINANTE UMANA - SOLUZIONE PER INIEZIONE SOTTOCUTANEA(MABTHERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/98/067/001-003, 20140326
93138 Luxembourg   Start Trial PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
91902 Luxembourg   Start Trial 91902, EXPIRES: 20260523
122015000061 Germany   Start Trial PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
C300509 Netherlands   Start Trial PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001 - 002 20110617
300822 Netherlands   Start Trial PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Colorcon
Baxter
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.